Cargando…
Association of Endocrine Therapy Initiation Timeliness With Adherence and Continuation in Low-Income Women With Breast Cancer
IMPORTANCE: Though adjuvant endocrine therapy (AET) has proven efficacy in treating hormone receptor–positive (HR-positive) breast cancer, patient adherence to AET and continuation of treatment as recommended by guidelines remain suboptimal, especially for low-income patients. OBJECTIVE: To quantify...
Autores principales: | Sood, Nikita, Liu, Ying, Lian, Min, Greever-Rice, Tracy, Lucht, Jill, Schmaltz, Chester, Colditz, Graham A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350715/ https://www.ncbi.nlm.nih.gov/pubmed/35921108 http://dx.doi.org/10.1001/jamanetworkopen.2022.25345 |
Ejemplares similares
-
Timing of Medicaid Enrollment, Late-Stage Breast Cancer Diagnosis, Treatment Delays, and Mortality
por: Xie, Evaline, et al.
Publicado: (2022) -
The Timeliness Initiative: Continuous Process Improvement for Prompt Initiation of Radiation Therapy Treatment
por: Agazaryan, Nzhde, et al.
Publicado: (2020) -
Factors associated with initiation and continuation of endocrine therapy in women with hormone receptor-positive breast cancer
por: Cho, Beomyoung, et al.
Publicado: (2022) -
Impact of Patient Navigation on Timeliness of Diagnosis and Treatment, and Adherence to Treatment in Middle Income Asian Country
por: Jaganathan, Maheswari, et al.
Publicado: (2022) -
Timeliness and Modality of Treatment for New Cancer Diagnoses During the COVID-19 Pandemic in Canada
por: Fu, Rui, et al.
Publicado: (2023)